← FDA Drug Approvals (Drugs@FDA)

DEXTROSE 5% AND SODIUM CHLORIDE 0.9%

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2020-09-14

Drug application

FDA Application #

ANDA211211

Application type

Abbreviated New Drug Application (Generic)

Brand name

DEXTROSE 5% AND SODIUM CHLORIDE 0.9%

Generic name

DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE

Active ingredients

DEXTROSE; SODIUM CHLORIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

2020-09-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown